Skip to main content
ORTHOCELL LIMITED logo

ORTHOCELL LIMITED — Investor Relations & Filings

Ticker · OCC ISIN · AU000000OCC6 ASX Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2023-10-29 Share Issue/Capital Cha…
Country AU Australia
Listing ASX OCC

About ORTHOCELL LIMITED

https://orthocell.com/

Orthocell Limited is a regenerative medicine company focused on the development and commercialization of innovative technologies for the repair and regeneration of human soft tissue. The company’s core product portfolio includes the CelGro platform, a naturally derived collagen medical device designed to facilitate tissue repair and reconstruction in applications such as dental bone and soft tissue regeneration, nerve repair, and tendon repair. Orthocell also specializes in advanced cellular therapies, notably Ortho-ATI (Autologous Tenocyte Implantation) for treating chronic tendon injuries and Ortho-ACI (Autologous Chondrocyte Implantation) for cartilage repair. These therapies utilize a patient's own cells to restore function and structure to damaged tissues. The company aims to provide restorative solutions that improve clinical outcomes and offer alternatives to traditional surgical interventions.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - OCC 8 pages 30.3KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Application for quotation of +securities' and details the application for quotation of securities issued by Orthocell Limited. It references securities issued as part of a previously announced transaction (Appendix 3B) and provides detailed information about the securities to be quoted, issue dates, distribution schedules, and issued capital following quotation. There is no financial performance data, earnings information, management discussion, or regulatory certification. The document is an official announcement related to the listing or quotation of securities on the ASX, which aligns with announcements about share issues or capital changes. Therefore, this document fits best under the category of Share Issue/Capital Change (SHA). The document length is over 6000 characters and contains substantive details about the securities issuance and quotation, not merely a brief announcement or a report publication notice.
2023-10-29 English
Cleansing Notice 1 page 128.1KB
Share Issue/Capital Change Classification · 100% confidence The document is a notice under Section 708A(5)(e) of the Corporations Act regarding the issuance of fully paid ordinary shares by Orthocell Limited. It details the issuance of shares pursuant to an agreement and compliance with relevant sections of the Corporations Act. The document is short (3195 characters) and serves as an announcement of a share issue rather than a full financial report or detailed filing. It does not contain financial statements or detailed analysis but rather a regulatory notice about a capital transaction. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2023-10-29 English
Professor Fiona Wood AM joins Orthocell Board 3 pages 247.2KB
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of Professor Fiona Wood AM to the Board of Orthocell Limited, along with other board changes such as the retirement of a member and transition of another director. It details the professional background of the new appointee, the strategic importance of the appointment, and the company's current board composition. There is no financial data, no discussion of financial results, no regulatory filings, no voting results, no legal proceedings, no capital changes, and no mention of any report publication. The content focuses solely on board/management changes. Therefore, the document fits the category of Board/Management Information (MANG). The document length (9192 characters) and detailed content about board appointments support this classification with high confidence.
2023-10-24 English
Proposed issue of securities - OCC 5 pages 28.4KB
Capital/Financing Update Classification · 95% confidence The document is an announcement from Orthocell Limited regarding a proposed issue of securities, specifically options exercisable at a certain price and date. It details the number of securities, the terms of the issue, the proposed issue date, and compliance with ASX listing rules. There is no financial performance data, management discussion, or audit information. The document is focused on informing about a capital raising or securities issuance event. This fits the definition of a Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive details about the securities issue, not just a brief notice or link to a report, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the correct classification is CAP with high confidence.
2023-10-24 English
Quarterly Activity Report & Appendix 4C 9 pages 474.1KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Report – September 2023' and contains detailed financial and operational information for the quarter ended 30 September 2023. It includes revenue figures, product sales growth, distributor updates, clinical trial progress, cash balances, and board changes. The length is about 15,000 characters, indicating a substantive report rather than a brief announcement. The content includes actual financial data and analysis for a period shorter than a full fiscal year (quarterly), consistent with an Interim / Quarterly Report. There is no indication that this is merely an announcement of a report or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2023-10-16 English
Notification of cessation of securities - OCC 5 pages 25.3KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Notification of cessation of +securities' and details the expiry of options (convertible securities) for Orthocell Limited. It provides specific information about the securities that have ceased, the reason for cessation (expiry without exercise or conversion), and the updated issued capital following these changes. The document is an announcement about changes in the company's issued securities, specifically the cessation of certain options. It does not contain financial statements, management discussion, or detailed financial results. It is not a report but an official notification of a capital change event related to securities. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length is 4534 characters, which is consistent with an announcement rather than a full report.
2023-10-08 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.